NCT03394664

Brief Summary

This study will evaluate the effects of dietary carbohydrate and sugar consumption, independent of energy content, on body fatness and metabolism in a rigorous feeding study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 9, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

May 9, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2020

Completed
Last Updated

June 18, 2021

Status Verified

October 1, 2020

Enrollment Period

2 years

First QC Date

December 29, 2017

Last Update Submit

June 17, 2021

Conditions

Keywords

Body compositionFeeding studyKetogenic dietWeight lossEnergy Expenditure

Outcome Measures

Primary Outcomes (1)

  • Body fat mass

    Body composition assessed using a multi-component model

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

Secondary Outcomes (33)

  • Lean body mass

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Body weight

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Total energy expenditure (TEE)

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Resting energy expenditure (REE)

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Physical activity level, (moderate to vigorous)

    Measurements made daily during 2 weeks at PWL, 2 weeks at END, and alternating non-assessment weeks of the residential phase and integrated into a unified outcome

  • +28 more secondary outcomes

Other Outcomes (34)

  • 1,5-anhydroglucitol (1,5-AG)

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Lipoprotein particle subfraction distribution

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • Fibrinogen

    Change from post-weight loss (PWL, 0 weeks) to end of residential study (END, 10 weeks)

  • +31 more other outcomes

Study Arms (3)

Very-Low Carbohydrate Diet

EXPERIMENTAL

Feeding study. Dietary composition (approximately): 75% fat

Behavioral: Feeding Study

High-Carbohydrate Low-Sugar Diet

EXPERIMENTAL

Feeding study. Dietary composition (approximately): 25% fat 0% added sugars.

Behavioral: Feeding Study

High-Carbohydrate High-Sugar Diet

EXPERIMENTAL

Feeding study. Dietary composition (approximately): 25% fat, 20% added sugars.

Behavioral: Feeding Study

Interventions

Feeding StudyBEHAVIORAL

Food provision throughout the study: 1) Run-In Phase (VLC diet, weight loss); 2) Residential Phase (3 different test diets, weight-loss maintenance).

Also known as: weight loss, weight-loss maintenance
High-Carbohydrate High-Sugar DietHigh-Carbohydrate Low-Sugar DietVery-Low Carbohydrate Diet

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18 to 50 years
  • BMI ≥ 27 kg/m2
  • Weight ≤ 350 lb
  • Medical clearance from a primary care provider
  • Willingness to follow a VLC weight-loss diet
  • Willingness to reside in a research unit for 3 months and eat/drink only provided study foods and beverages
  • No major food allergies or aversions
  • Willingness to obtain seasonal flu shot or provide documentation of flu shot for current flu season (winter/spring cohort only)
  • Willingness to discuss work options (e.g., remote work) with employer, and make appropriate arrangements prior to the Residential phase.

You may not qualify if:

  • Change in body weight ≥ 10% during prior 6 months
  • Specialized diets (e.g., for medical or religious reasons)
  • Chronic use of any medication or dietary supplement that could affect study outcomes (e.g., insulin, metformin, thyroxine)
  • Current smoking (1 cigarette in the last week)
  • Greater than moderate alcohol consumption (\> 14 drinks/wk) or history of binge drinking (≥5 drinks in 1 day within past 6 months)
  • Physician diagnosis of a major medical illness or eating disorder
  • History of kidney stones
  • Laboratory tests: ALT\>2x upper limit; abnormal HgA1c; abnormal TSH; abnormal creatinine; abnormal uric acid (using the male upper limit for both sexes)
  • Failed criminal offender background check or sex offender background check
  • Use of recreational drugs
  • Current diagnosis or history of kidney stones, gout, or gall stones; or removal of gall bladder
  • Exercise restrictions or at high risk for complications during exercise
  • Menopausal
  • Any change in birth control medication during the 3 months prior to enrollment
  • Pregnancy or lactation during the 12 months prior to enrollment, or intent to become pregnant during study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Warren Conference Center and Inn

Ashland, Massachusetts, 01721, United States

Location

Related Publications (5)

  • Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014 Jun 4;311(21):2167-8. doi: 10.1001/jama.2014.4133. No abstract available.

    PMID: 24839118BACKGROUND
  • Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.

    PMID: 22735432BACKGROUND
  • Wong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Wong JMW, Ebbeling CB, Ludwig DS, Irving BA, Scott MC, Stampley J, Davis B, Johannsen N, Matthews R, Vincellette C, Garber AK, Maskarinec G, Weiss E, Rood J, Varanoske AN, Pasiakos SM, Heymsfield SB, Shepherd JA. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023 Apr;117(4):802-813. doi: 10.1016/j.ajcnut.2023.02.006. Epub 2023 Feb 14.

  • Jansen LT, Yang N, Wong JMW, Mehta T, Allison DB, Ludwig DS, Ebbeling CB. Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial. Diabetes Care. 2022 Mar 1;45(3):576-584. doi: 10.2337/dc21-1970.

  • Wong JMW, Yu S, Ma C, Mehta T, Dickinson SL, Allison DB, Heymsfield SB, Ebbeling CB, Ludwig DS. Stimulated Insulin Secretion Predicts Changes in Body Composition Following Weight Loss in Adults with High BMI. J Nutr. 2022 Mar 3;152(3):655-662. doi: 10.1093/jn/nxab315.

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • David S Ludwig, MD, PhD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR
  • David B Allison, PhD

    Indiana University, Bloomington

    PRINCIPAL INVESTIGATOR
  • Cara B Ebbeling, PhD

    Boston Children's Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Assessors conducting analyses of biospecimens, laboratory personnel, DXA technologists, and research nurses were blinded to random group assignment. They were not involved in the randomization process or any aspects of the intervention. The statistical team worked with masked labels for the diet arms.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Director, New Balance Foundation Obesity Prevention Center

Study Record Dates

First Submitted

December 29, 2017

First Posted

January 9, 2018

Study Start

May 9, 2018

Primary Completion

May 3, 2020

Study Completion

May 3, 2020

Last Updated

June 18, 2021

Record last verified: 2020-10

Locations